Jean F. Voltaire

Array ( [id] => 8725581 [patent_doc_number] => 08404697 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Quinazoline derivatives for the treatment of cancer diseases' [patent_app_type] => utility [patent_app_number] => 12/093321 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8881 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12093321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5421990 [patent_doc_number] => 20090148445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'METHODS OF SENSITIZING CANCER TO THERAPY-INDUCED CYTOTOXICITY' [patent_app_type] => utility [patent_app_number] => 12/282343 [patent_app_country] => US [patent_app_date] => 2006-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 13077 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148445.pdf [firstpage_image] =>[orig_patent_app_number] => 12282343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057715 [patent_doc_number] => 20070060637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Anti-cancer combinations' [patent_app_type] => utility [patent_app_number] => 11/592678 [patent_app_country] => US [patent_app_date] => 2006-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10357 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060637.pdf [firstpage_image] =>[orig_patent_app_number] => 11592678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6606383 [patent_doc_number] => 20100063162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'METHOD FOR PREDICTING EFFICACY OF RAR-ALPHA AGONIST' [patent_app_type] => utility [patent_app_number] => 12/091091 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5655 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063162.pdf [firstpage_image] =>[orig_patent_app_number] => 12091091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 269167 [patent_doc_number] => RE040862 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2009-07-21 [patent_title] => 'Gossypolone for the treatment of cancer' [patent_app_type] => reissue [patent_app_number] => 11/581734 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3482 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/040/RE040862.pdf [firstpage_image] =>[orig_patent_app_number] => 11581734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6339192 [patent_doc_number] => 20100247427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Methods of inhibiting cell growth and methods of enhancing radiation responses' [patent_app_type] => utility [patent_app_number] => 11/581293 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5788 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247427.pdf [firstpage_image] =>[orig_patent_app_number] => 11581293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711773 [patent_doc_number] => 20080300299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Application of Eriocalyxin B in the Manufacture of Medicaments For Treating Leukemia' [patent_app_type] => utility [patent_app_number] => 12/092914 [patent_app_country] => US [patent_app_date] => 2006-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7138 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300299.pdf [firstpage_image] =>[orig_patent_app_number] => 12092914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682171 [patent_doc_number] => 20100022637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'IDENTIFICATION OF ANTI-CANCER COMPOUNDS AND COMPOUNDS FOR TREATING HUNTINGTON\'S DISEASE AND METHODS OF TREATMENT THEREOF' [patent_app_type] => utility [patent_app_number] => 11/992867 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 76 [patent_figures_cnt] => 76 [patent_no_of_words] => 26839 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022637.pdf [firstpage_image] =>[orig_patent_app_number] => 11992867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5242828 [patent_doc_number] => 20070021323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/524753 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5912 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021323.pdf [firstpage_image] =>[orig_patent_app_number] => 11524753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9427678 [patent_doc_number] => 08703753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-22 [patent_title] => 'Use of tellurium compounds for the treatment of actinic keratosis' [patent_app_type] => utility [patent_app_number] => 12/517222 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15218 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12517222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569863 [patent_doc_number] => 20100234463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Method for Identifying Modulators of Gamma Secretase or Notch' [patent_app_type] => utility [patent_app_number] => 11/991586 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7304 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234463.pdf [firstpage_image] =>[orig_patent_app_number] => 11991586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142542 [patent_doc_number] => 20070004758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE' [patent_app_type] => utility [patent_app_number] => 11/469417 [patent_app_country] => US [patent_app_date] => 2006-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 50220 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004758.pdf [firstpage_image] =>[orig_patent_app_number] => 11469417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262558 [patent_doc_number] => 20100297112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/064633 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5853 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297112.pdf [firstpage_image] =>[orig_patent_app_number] => 12064633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441411 [patent_doc_number] => 20100104565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'COMBINATIONS COMPRISING DMXAA FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/064632 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4286 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104565.pdf [firstpage_image] =>[orig_patent_app_number] => 12064632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759431 [patent_doc_number] => 20080311657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Killing Human Lymphoma and Leukemia Cancer Cells and Tcr-Activated Normal Human Cells By Dopamine D1r Agonists' [patent_app_type] => utility [patent_app_number] => 11/997848 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 11891 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311657.pdf [firstpage_image] =>[orig_patent_app_number] => 11997848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698942 [patent_doc_number] => 20080221126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Use of Hdac Inhibitors for the Treatment of Myeloma' [patent_app_type] => utility [patent_app_number] => 11/996323 [patent_app_country] => US [patent_app_date] => 2006-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8410 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221126.pdf [firstpage_image] =>[orig_patent_app_number] => 11996323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205693 [patent_doc_number] => 20070027175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Antineoplastic activities of ellipticine and its derivatives' [patent_app_type] => utility [patent_app_number] => 11/494335 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12263 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027175.pdf [firstpage_image] =>[orig_patent_app_number] => 11494335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5890239 [patent_doc_number] => 20060276547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Methods of treating cancer with HDAC inhibitors' [patent_app_type] => utility [patent_app_number] => 11/492478 [patent_app_country] => US [patent_app_date] => 2006-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24086 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276547.pdf [firstpage_image] =>[orig_patent_app_number] => 11492478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5243002 [patent_doc_number] => 20070021497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'VITAMIN E COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 11/456693 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3178 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20070021497.pdf [firstpage_image] =>[orig_patent_app_number] => 11456693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835355 [patent_doc_number] => 20060247186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers' [patent_app_type] => utility [patent_app_number] => 11/480360 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9303 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247186.pdf [firstpage_image] =>[orig_patent_app_number] => 11480360 [rel_patent_id] =>[rel_patent_doc_number] =>)